ADMA Biologics Inc
NASDAQ:ADMA
ADMA Biologics Inc
Interest Income Expense
ADMA Biologics Inc
Interest Income Expense Peer Comparison
Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors
Company | Interest Income Expense | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
ADMA Biologics Inc
NASDAQ:ADMA
|
Interest Income Expense
-$20.8m
|
CAGR 3-Years
-19%
|
CAGR 5-Years
-31%
|
CAGR 10-Years
-41%
|
|
Abbvie Inc
NYSE:ABBV
|
Interest Income Expense
-$1.8B
|
CAGR 3-Years
8%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-19%
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Interest Income Expense
-$757m
|
CAGR 3-Years
35%
|
CAGR 5-Years
0%
|
CAGR 10-Years
-10%
|
|
Amgen Inc
NASDAQ:AMGN
|
Interest Income Expense
-$2.9B
|
CAGR 3-Years
-44%
|
CAGR 5-Years
-30%
|
CAGR 10-Years
-16%
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Interest Income Expense
$563.1m
|
CAGR 3-Years
78%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Interest Income Expense
$221.8m
|
CAGR 3-Years
-13%
|
CAGR 5-Years
75%
|
CAGR 10-Years
N/A
|
See Also
What is ADMA Biologics Inc's Interest Income Expense?
Interest Income Expense
-20.8m
USD
Based on the financial report for Mar 31, 2024, ADMA Biologics Inc's Interest Income Expense amounts to -20.8m USD.
What is ADMA Biologics Inc's Interest Income Expense growth rate?
Interest Income Expense CAGR 10Y
-41%
Over the last year, the Interest Income Expense growth was 5%. The average annual Interest Income Expense growth rates for ADMA Biologics Inc have been -19% over the past three years , -31% over the past five years , and -41% over the past ten years .